Try our Advanced Search for more refined results
LoConte et al v. Forest Laboratories, Inc.
Case Number:
1:14-cv-13848
Court:
Nature of Suit:
Racketeer/Corrupt Organization
Multi Party Litigation:
Class Action
Judge:
Firms
Companies
Sectors & Industries:
-
January 29, 2018
Forest Beats Final Cases In Celexa, Lexapro MDL
Forest Laboratories Inc. prevailed on Monday against claims by a health and benefit fund and a pair of mothers that it fraudulently promoted Celexa and Lexapro for pediatric depression, putting long-running Massachusetts multidistrict litigation against the company to rest.
-
January 25, 2018
Forest Beats Bid For More Docs In Celexa, Lexapro MDL
Forest Laboratories Inc. can't be forced to hand over more documents tied to a clinical study into antidepressants and children in a suit by parents and a health fund accusing the company of fraudulently promoting Celexa and Lexapro for pediatric depression, a Massachusetts federal judge ruled Tuesday.
-
January 03, 2018
Drug Buyers Can't Get Forest Labs Docs Related To Probe
A Massachusetts federal judge on Tuesday ruled Forest Laboratories can't be forced to produce documents from a congressional probe into the use of antidepressants in children, rejecting objections from parents accusing the company of fraudulently promoting Celexa and Lexapro for pediatric depression.
-
March 02, 2017
Celexa, Lexapro Buyers Want Class Cert. In Marketing MDL
Two mothers accusing Forest Laboratories Inc. of misleading consumers about the efficacy of its antidepressants Celexa and Lexapro for children on Thursday asked for class certification, telling a Massachusetts federal court that proof of a greater fraud eliminates the need to handle anti-racketeering claims on a case-by-case basis.
-
September 26, 2016
Judge Orders Depositions Of Ex-Forest Labs Employees
A Boston federal judge has granted a motion to compel six new depositions of former Forest Laboratories Inc. officials in a suit over the effectiveness of Celexa and Lexapro in children, but also denied a bid by plaintiffs in the multidistrict litigation to compel new documents.
-
September 07, 2016
Depositions Repetitive In Celexa, Lexapro MDL, Forest Says
Forest Laboratories Inc. on Tuesday asked a Massachusetts federal court not to make six former employees sit for depositions in multidistrict litigation accusing the company of misleading consumers about the efficacy of its drugs Celexa and Lexapro, arguing discovery has been extensive enough and most of them have already been questioned.
-
June 09, 2016
Potential Class Action Can Proceed In Celexa, Lexapro MDL
A Massachusetts federal judge on Thursday refused to dismiss a potential class action accusing Forest Laboratories Inc. in multidistrict litigation of misleading consumers about the efficacy of its drugs Celexa and Lexapro in treating pediatric depression, finding a mother properly alleged plausible Racketeer Influenced and Corrupt Organizations Act claims.